Champions Oncology Inc reports results for the quarter ended in April - Earnings Summary

Champions Oncology

22/07/2024 22:01

* Champions Oncology Inc  CSBR.OQ  reported quarterly
adjusted
earnings of 1 cent​​ per share for the quarter ended in April,
higher than the same quarter last year, when the company
reported EPS of -19 cents.  The lone analyst forecast for the
quarter was for a loss of 16 cents per share. 
    * Revenue rose 7.1% to $14.00 million from a year ago;
analysts
expected $12.69 million. 
    * Champions Oncology Inc's reported EPS for the quarter was
a loss
of 1 cent​.
    * Champions Oncology Inc shares had fallen by 2.4% this
quarter and lost 10.2% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "hold"

Wall Street's median 12-month price target for Champions
Oncology Inc is $6.00 
This summary was machine generated from LSEG data July 22 at
09:00 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Apr. 30 2024      -0.16          0.01           Beat
 Jan. 31 2024      -0.06          -0.16          Missed
 Oct. 31 2023      -0.17          -0.15          Beat
 Jul. 31 2023      -0.11          -0.19          Missed